# Martin Marietta Materials Inc: Form 10-Q for the period ended Sep 30, 2017

- Company: [Martin Marietta Materials Inc](/companies/mlm.md) (CIK 916076)
- Form: 10-Q
- Filed: 2017-11-02
- Accepted by EDGAR: Nov 2, 2017, 16:41 ET
- Period: 2017-09-30
- Accession: 0001564590-17-021253
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/916076/000156459017021253/mlm-10q_20170930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/916076/000156459017021253/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-07-01 to 2017-09-30 | $796.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2017-01-01 to 2017-09-30 | $2.28bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2017-07-01 to 2017-09-30 | $291.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2017-01-01 to 2017-09-30 | $712.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2017-07-01 to 2017-09-30 | $57.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2017-01-01 to 2017-09-30 | $195.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-07-01 to 2017-09-30 | $227.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2017-01-01 to 2017-09-30 | $517.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-07-01 to 2017-09-30 | $23.1m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2017-01-01 to 2017-09-30 | $68.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-07-01 to 2017-09-30 | $52.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2017-01-01 to 2017-09-30 | $119.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-07-01 to 2017-09-30 | $151.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2017-01-01 to 2017-09-30 | $336.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-07-01 to 2017-09-30 | $2.39 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2017-01-01 to 2017-09-30 | $5.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-07-01 to 2017-09-30 | $2.40 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2017-01-01 to 2017-09-30 | $5.33 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-07-01 to 2017-09-30 | 63,158,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2017-01-01 to 2017-09-30 | 63,218,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2017-01-01 to 2017-09-30 | $418.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2017-01-01 to 2017-09-30 | $308.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2017-01-01 to 2017-09-30 | $81.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2017-01-01 to 2017-09-30 | $100.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-09-30 | $35.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-09-30 | $1.28bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-09-30 | $7.57bn | us-gaap:Assets |
| Current liabilities | at 2017-09-30 | $468.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-09-30 | $3.23bn | us-gaap:Liabilities |
| Long-term debt | at 2017-09-30 | $1.64bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-09-30 | $80.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2017-09-30 | $4.33bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/916076/000156459017021253/mlm-10q_20170930.htm

Filed Nov 2, 2017.
Source: SEC EDGAR, the filing index for accession 0001564590-17-021253. Last ingested by Listed: Nov 10, 2026, 17:16 ET. No prices; not investment advice.
